Partha Bagchi

510 total citations
10 papers, 402 citations indexed

About

Partha Bagchi is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Partha Bagchi has authored 10 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Partha Bagchi's work include Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Pneumonia and Respiratory Infections (2 papers). Partha Bagchi is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Pneumonia and Respiratory Infections (2 papers). Partha Bagchi collaborates with scholars based in United States, Costa Rica and Canada. Partha Bagchi's co-authors include Gary J. Noel, Richard Strauß, Karen Bush, Juliana Ianus, Jeffrey L. Blumer, Dainius Balis, Adriano Arguedas, Ciarán M. Duffy, Ralph E. Kauffman and Peter G. Gerbino and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Partha Bagchi

10 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Partha Bagchi United States 8 185 136 118 93 85 10 402
Miguel Sánchez Spain 8 67 0.4× 68 0.5× 153 1.3× 48 0.5× 53 0.6× 16 421
Nan Bai China 10 133 0.7× 66 0.5× 90 0.8× 61 0.7× 19 0.2× 22 335
Amy L. Graziani United States 10 164 0.9× 109 0.8× 170 1.4× 48 0.5× 35 0.4× 20 436
Cumhur Y. Demirkale United States 10 84 0.5× 58 0.4× 174 1.5× 102 1.1× 28 0.3× 19 488
Jeanne D. Breen United States 9 90 0.5× 84 0.6× 204 1.7× 28 0.3× 56 0.7× 10 428
Noa Zemer‐Wassercug Israel 10 133 0.7× 54 0.4× 101 0.9× 80 0.9× 48 0.6× 10 389
Delphine Croisier France 14 142 0.8× 155 1.1× 155 1.3× 37 0.4× 26 0.3× 32 466
Žilvinas Endzinas Lithuania 9 219 1.2× 56 0.4× 65 0.6× 135 1.5× 90 1.1× 24 480
V Drossou-Agakidou Greece 10 77 0.4× 109 0.8× 126 1.1× 45 0.5× 101 1.2× 14 380
Jacqueline Bork United States 11 128 0.7× 106 0.8× 129 1.1× 155 1.7× 85 1.0× 35 443

Countries citing papers authored by Partha Bagchi

Since Specialization
Citations

This map shows the geographic impact of Partha Bagchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Partha Bagchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Partha Bagchi more than expected).

Fields of papers citing papers by Partha Bagchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Partha Bagchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Partha Bagchi. The network helps show where Partha Bagchi may publish in the future.

Co-authorship network of co-authors of Partha Bagchi

This figure shows the co-authorship network connecting the top 25 collaborators of Partha Bagchi. A scholar is included among the top collaborators of Partha Bagchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Partha Bagchi. Partha Bagchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dagan, Ron, Shai Ashkenazi, Gilat Livni, et al.. (2016). Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12–15 Months of Age. The Pediatric Infectious Disease Journal. 35(7). e220–e228. 10 indexed citations
2.
3.
Kimko, Holly, Xu Xu, Partha Nandy, et al.. (2009). Pharmacodynamic Profiling of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 53(8). 3371–3374. 15 indexed citations
4.
Noel, Gary J., Karen Bush, Partha Bagchi, Juliana Ianus, & Richard Strauß. (2008). A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections. Clinical Infectious Diseases. 46(5). 647–655. 207 indexed citations
5.
Noel, Gary J., Jeffrey L. Blumer, Michael E. Pichichero, et al.. (2008). A Randomized Comparative Study of Levofloxacin Versus Amoxicillin/Clavulanate for Treatment of Infants and Young Children With Recurrent or Persistent Acute Otitis Media. The Pediatric Infectious Disease Journal. 27(6). 483–489. 31 indexed citations
6.
Noel, Gary J., John S. Bradley, Ralph E. Kauffman, et al.. (2007). Comparative Safety Profile of Levofloxacin in 2523 Children With a Focus on Four Specific Musculoskeletal Disorders. The Pediatric Infectious Disease Journal. 26(10). 879–891. 86 indexed citations
7.
Catalano, Robert B., et al.. (1995). Phase II Evaluation of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (M-VAC) in Advanced, Measurable Breast Carcinoma. Cancer Investigation. 13(2). 150–159. 8 indexed citations
8.
Bagchi, Partha, et al.. (1993). Compound regressive models for quantitative multivariate phenotypes: Application to lipid and lipoprotein data. Genetic Epidemiology. 10(6). 647–651. 2 indexed citations
9.
Curran, Walter J., Steven M. Keller, Robert B. Catalano, et al.. (1993). Report of phase ii trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky iiia non-small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 26(3). 469–478. 24 indexed citations
10.
Langer, Corey J., Norman D. Rosenblum, Michael Hogan, et al.. (1993). Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach. Cancer Chemotherapy and Pharmacology. 32(3). 204–208. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Sánchez Breakdown of academic impact, for papers by Nan Bai Breakdown of academic impact, for papers by Amy L. Graziani Breakdown of academic impact, for papers by Cumhur Y. Demirkale Breakdown of academic impact, for papers by Jeanne D. Breen Breakdown of academic impact, for papers by Noa Zemer‐Wassercug Breakdown of academic impact, for papers by Delphine Croisier Breakdown of academic impact, for papers by Žilvinas Endzinas Breakdown of academic impact, for papers by V Drossou-Agakidou Breakdown of academic impact, for papers by Jacqueline Bork
Rankless by CCL
2026